Forma Therapeutics Taps Ex-Seres Exec Cook as Chief Scientific Officer

Forma Therapeutics has appointed David Cook to serve as its senior vice president and chief scientific officer. Cook’s experience includes senior roles at Seres Therapeutics (NASDAQ: [[ticker:MCRB]]), the International AIDS Vaccine Initiative, Anza Therapeutics, and Cerus Corporation. Watertown, MA-based Forma develops drugs for rare blood diseases and cancers. The company’s most advanced program, olutasidenib, is currently in a pivotal study testing it as a treatment for acute myeloid leukemia.

Author: Frank Vinluan

Xconomy Editor Frank Vinluan is a business journalist with experience covering technology and life sciences. Based in Raleigh, he was a staff writer at the Triangle Business Journal covering technology, biotechnology and energy before joining MedCityNews.com as North Carolina bureau chief. Prior to moving to North Carolina’s Research Triangle in 2007 he held business reporting positions at The Des Moines Register and The Seattle Times.